SAFETY OF MID-TRIMESTER ABORTIONS — The Design of a Recent US Comparative Trial Comes in for Criticism Newsletter Article 12 February 2013 Pages: 2 - 2
PHENFORMIN WARNING LETTER TO AMERICAN DOCTORS — Lactic Acidosis: An Unnecessary Risk for Diabetics Newsletter Article 12 February 2013 Pages: 2 - 2
AVITENE: A NEW TOPICAL HAEMOSTATIC AGENT — It Has Its Uses, But ‘Is No Substitute for a Well-placed Suture’! Newsletter Article 12 February 2013 Pages: 3 - 4
ANTICONVULSANTS IN PREGNANCY CREATE PROBLEMS — Not Only in the Mother but also in the Neonate Newsletter Article 12 February 2013 Pages: 4 - 4
RESISTANCE TO CEPHALOTHIN IN BACTERIAL ENDOCARDITIS — FIRST REPORT Newsletter Article 12 February 2013 Pages: 4 - 4
A FURTHER CASE OF LIVER DAMAGE WITH PERHEXILINE MALEATE Newsletter Article 12 February 2013 Pages: 6 - 6
GRANULOCYTE TRANSFUSIONS AID INFECTED GRANULOCYTOPENIC PATIENTS — But Is Their Routine Use Desirable? Newsletter Article 12 February 2013 Pages: 8 - 9
ORAL ZINC SULPHATE HAS A ‘REMARKABLE’ EFFECT IN ACNE Newsletter Article 12 February 2013 Pages: 9 - 9
CLOFIBRATE HAS IMPORTANT EFFECTS IN DIABETES MELLITUS Newsletter Article 12 February 2013 Pages: 10 - 10
CYCLOFENIL LOOKS PROMISING IN PROGRESSIVE SYSTEMIC SCLEROSIS Newsletter Article 12 February 2013 Pages: 12 - 12
ANCROD: A NEW APPROACH TO INTERMITTENT CLAUDICATION Newsletter Article 12 February 2013 Pages: 12 - 12
PROSTAGLANDIN E1 IS EFFECTIVE FOR DUCTUS ARTERIOSUS DILATION IN NEONATES Newsletter Article 12 February 2013 Pages: 13 - 13
CEPHAPIRIN AND CEPHALOTHIN ARE PHARMACOKINETICALLY EQUIVALENT Newsletter Article 12 February 2013 Pages: 16 - 16
SLOW-RELEASE HYDRALLAZINE PROMISES TWICE-DAILY DOSING — Possibly with Fewer Side-Effects Newsletter Article 12 February 2013 Pages: 16 - 16
PASSING THE BUCK IN OESTROGEN THERAPY! — An Adequately Informed Patient Must be the Final Judge Newsletter Article 12 February 2013 Pages: 17 - 17
DRUGS TAKE SECOND PLACE TO DIET IN TREATING HYPERLIPIDAEMIA — Side-Effects Limit Their Usefulness Newsletter Article 12 February 2013 Pages: 18 - 18
PROBUCOL (‘Lorelco’; Dow) — A New Antihyperlipidaemic Recently Introduced in the US Newsletter Article 12 February 2013 Pages: 19 - 19